openPR Logo
Press release

Biologics Market Size Worth USD 769.7 Billion by 2033 | CAGR 7.38%

01-07-2025 01:22 PM CET | Health & Medicine

Press release from: IMARC Group

Biologics Market

Biologics Market

The latest report by IMARC Group, titled "๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž, ๐’๐ก๐š๐ซ๐ž, ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐›๐ฒ ๐’๐จ๐ฎ๐ซ๐œ๐ž, ๐๐ซ๐จ๐๐ฎ๐œ๐ญ, ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž, ๐Œ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐ , ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘," offers a comprehensive analysis of the biologics market. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global biologics market size was valued at ๐”๐’๐ƒ ๐Ÿ‘๐Ÿ•๐Ÿ•.๐Ÿ” ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’. Looking forward, IMARC Group estimates the market to reach ๐”๐’๐ƒ ๐Ÿ•๐Ÿ”๐Ÿ—.๐Ÿ• ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘, exhibiting a ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ•.๐Ÿ‘๐Ÿ–% from 2025-2033.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.imarcgroup.com/biologics-market/requestsample

๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ:

โ€ข ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Changes in the Biologics market are increasing as a consequence of improved Biotechnology and growing investments in R&D. One of the more radical changes occurring within the industry is the move towards personalized medicine, wherein biologics are crafted to match the genetic make-up of a patient ensuring accuracy and efficiency of treatment. The increasing proportion of biosimilars however is changing everything for the better as they provide cheaper options to biologics without compromising on the effectiveness and safety.

Enhanced compliance is also realised through the innovations in drug delivery systems which include sustained-release formulations and needle-free devices. In conjunction with the growing partnership of pharmaceutical enterprises and biotechnology companies these developments point to a changing global economy where unmet health demands are being met in an efficient manner.

โ€ข ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ž ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

The growth of the biologics market continues to be impressive and is being driven by the increasing burden of chronic diseases such as cancer, autoimmune disorders, diabetes etc that require above basic treatment. There is significant investment being made by governments and private sector into biopharmaceuticals thereby improving the rate of innovations.

There is an increase in the supply of biologics manufacturing capacity especially in the developing world, which contributes to the increasing affordability and availability of the products. Additional to this, there are regulatory changes that are more favorable to the development of new therapies and biosimilars in terms of the approval time required. The application of AI and machine learning in the development of biologics is also transforming the industry by improving efficiencies, time to market and growth of the industry as a whole.

โ€ข ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐Ÿ๐จ๐ซ ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ

With demographic changes such as an increasing elderly population or increasing health awareness, the biologics market is likely to witness an acute growth in the future. The progress in genomic research and precision medicine will also facilitate producing highly targeted biologics to address an even larger number of therapeutic needs.

Furthermore, the increasing number of people suffering from rare diseases increases the need for orphan biologic drugs, thereby creating opportunities with served niches for the players in the market. Cell-free protein synthesis and bioprinting technologies are among the new production technologies that should help to lower prices and increase scope. As health care systems around the world seek to deliver value-based care, biologics are becoming integral in efforts to improve patient outcomes.

๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Changes in technology as well as a new focus on better service are seen as driving forces in the advancement of the biotechnology industry, and this can be seen in the biologics market as well. Several current developments, including the adoption of single-use bioprocessing and other technologies that streamline and enhance the production process, can be seen, especially with regard to low value-added outsourcing. The growing focus on sustainability has led to the formulation of green production technologies in line with the international community's environmental welfare objectives.

The healthcare sector's digital shift seeks to include the provision of big data and real world evidence in the applications for use in the development of biologics thereby improving the effectiveness and safety of treatment. The growing importance of biologics for the treatment of patients imposes the interaction of academia with the industry and the regulatory societies, which aims to provide solutions to global health issues. All these together show that we are headed towards a future full of possibilities with biologics as a major driving force in the evolution of the healthcare sector.

๐€๐ฌ๐ค ๐ญ๐จ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ: https://www.imarcgroup.com/request?type=report&id=3883&flag=C

๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐›๐ฒ ๐’๐จ๐ฎ๐ซ๐œ๐ž:

โ€ข Microbial
โ€ข Mammalian
โ€ข Others

The ๐ฆ๐ข๐œ๐ซ๐จ๐›๐ข๐š๐ฅ sources account for a majority share of ๐Ÿ“๐Ÿ–.๐Ÿ“%.

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐›๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ:

โ€ข Monoclonal Antibodies
โ€ข Vaccines
โ€ข Recombinant Proteins
โ€ข Antisense, RNAi, and Molecular Therapy
โ€ข Others

๐Œ๐จ๐ง๐จ๐œ๐ฅ๐จ๐ง๐š๐ฅ ๐š๐ง๐ญ๐ข๐›๐จ๐๐ข๐ž๐ฌ represent the largest segment with a share of ๐Ÿ”๐Ÿ”.๐Ÿ•%.

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐›๐ฒ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž:

โ€ข Oncology
โ€ข Immunological Disorders
โ€ข Cardiovascular Disorders
โ€ข Hematological Disorders
โ€ข Others

The ๐จ๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ segment holds the largest share of ๐Ÿ๐Ÿ–.๐Ÿ•%.

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐›๐ฒ ๐Œ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐ :

โ€ข Outsourced
โ€ข In-House

๐ˆ๐ง-๐ก๐จ๐ฎ๐ฌ๐ž manufacturing leads the market with an ๐Ÿ–๐Ÿ’.๐Ÿ–% share.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

โ€ข North America (USA, Canada)
โ€ข Europe (Germany, France, UK, Italy, Spain, Russia, others)
โ€ข Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, others)
โ€ข Middle East/Africa
โ€ข Latin America (Brazil, Mexico, others)

๐“๐จ๐ฉ ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‹๐ž๐š๐๐ž๐ซ๐ฌ:

โ€ข AbbVie Inc.
โ€ข Amgen Inc.
โ€ข AstraZeneca plc
โ€ข F. Hoffmann-La Roche Ltd
โ€ข GlaxoSmithKline plc
โ€ข Johnson & Johnson
โ€ข Merck KGaA
โ€ข Novartis AG
โ€ข Pfizer Inc.
โ€ข Sanofi

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐’:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
๐„๐ฆ๐š๐ข๐ฅ: sales@imarcgroup.com
๐“๐ž๐ฅ ๐๐จ:(๐ƒ) +91 120 433 0800
๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ: +1-631-791-1145

๐€๐›๐จ๐ฎ๐ญ ๐”๐’:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics Market Size Worth USD 769.7 Billion by 2033 | CAGR 7.38% here

News-ID: 3806241 • Views: โ€ฆ

More Releases from IMARC Group

Flexible Printed Circuits Manufacturing Plant Cost 2025: Industry Trends, Unit Setup, and Machinery
Flexible Printed Circuits Manufacturing Plant Cost 2025: Industry Trends, Unit S โ€ฆ
Setting up a flexible printed circuits manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Flexible Printed Circuits Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing aโ€ฆ
Needle Manufacturing Plant 2025: Project Report, Business Plan, Raw Materials, and Cost Analysis
Needle Manufacturing Plant 2025: Project Report, Business Plan, Raw Materials, a โ€ฆ
Setting up a needle manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Needle Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a needle manufacturing plant, coveringโ€ฆ
Edible Oil Manufacturing Plant Setup Cost 2025: CapEx/OpEx Analysis with Profitability Forecasts
Edible Oil Manufacturing Plant Setup Cost 2025: CapEx/OpEx Analysis with Profita โ€ฆ
Setting up an edible oil manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Edible Oil Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing an edible oilโ€ฆ
Copper Alloys Manufacturing Plant Setup Cost 2025: Layout, Machinery, Raw Materials, and Financial Outlook
Copper Alloys Manufacturing Plant Setup Cost 2025: Layout, Machinery, Raw Materi โ€ฆ
Setting up a copper alloys manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Copper Alloys Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a copper alloysโ€ฆ

All 5 Releases


More Releases for Biologics

Advanced Biologics Manufacturing Solutions Market Future Business Opportunities โ€ฆ
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417 Focused onโ€ฆ
Biologics Fill Finish Manufacturing Market 2024-2031: Global Industry Size, Shar โ€ฆ
According to a new report published by CoherentMI The Biologics Fill Finish Manufacturing Market is estimated to be valued at USD 5.41 Billion in 2024 and is expected to reach USD 9.04 Billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. Most recent Report, named "Biologics Fill Finish Manufacturing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers aโ€ฆ
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.ย  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031 Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industryโ€ฆ
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi โ€ฆ
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market What is theโ€ฆ
Spine Biologics Market Report 2024 - Spine Biologics Market Trends And Share
"The Business Research Company recently released a comprehensive report on the Global Spine Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sampleโ€ฆ
Biologics Contract Manufacturing Market - Strategic biologics manufacturing part โ€ฆ
Newark, New Castle, USA: The "Biologics Contract Manufacturing Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biologics Contract Manufacturing Market: https://www.growthplusreports.com/report/biologics-contract-manufacturing-market/8606 This latest report researches the industry structure,โ€ฆ